Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAME: Fampyra Outcome Measures in MS
NCT01656148Phase 4Completed
- Sponsor
- University of Southern Denmark
- Start
- Jun 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dalfampridine in multiple sclerosis (MS), sponsored by University of Southern Denmark. Started Jun 2012; status: completed.
02
Drugs
dalfampridine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01656148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01656148.